Immunological measurements (IMAGE)
Caption
Based on the proven MCR microarray analysis platform of the Munich-based GWK Praezisionstechnik GmbH scientists at the Technical University of Munich have developed a new microarray-based rapid test for SARS-CoV-2 antibodies. The image shows the comparison of the results of the CoVRapid test of persons without immunization against SARS-CoV-2 (left), with immunization by vaccination and with immunization after infection (right).
Credit
Julia Kluepfel / TUM
Usage Restrictions
Free for reporting on Technical University of Munich.
License
Licensed content